Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 6Endocrine 3Lymphoid 2Other 1

Conditions

Lymphoma 1600Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Leukemia, Lymphocytic, Chronic, B-Cell 1090Lymphoma, Follicular 979Lymphoma, Large B-Cell, Diffuse 853Leukemia 790Hodgkin Disease 777Lymphoma, Mantle-Cell 675Leukemia, Myeloid, Acute 540Burkitt Lymphoma 507Lymphoma, B-Cell, Marginal Zone 490Multiple Myeloma 483Myelodysplastic Syndromes 371Lymphoma, Large-Cell, Immunoblastic 366Recurrence 363Lymphoma, T-Cell, Cutaneous 313Neoplasms 309Waldenstrom Macroglobulinemia 307Lymphoma, Large-Cell, Anaplastic 254Mycosis Fungoides 252Lymphoma, B-Cell 231Sezary Syndrome 229Blast Crisis 210Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 208Myeloproliferative Disorders 205Leukemia, Myelogenous, Chronic, BCR-ABL Positive 189Neoplasms, Plasma Cell 188Leukemia, Myeloid, Accelerated Phase 186Leukemia, Myeloid, Chronic-Phase 179

Interventions

Testosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hypogonadism × Lymphoid × Clear all
NCT04630275 2023-04-25

Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs

Herlev Hospital

Completed
172 enrolled
Lymphoid

Hypogonadism, Lymphoma, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Sexuality

NCT04492553 2022-11-29

Vitality

Herlev Hospital

Phase 2 Completed
7 enrolled
Lymphoid

Hypogonadism, Lymphoma, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡